Works matching IS 13419625 AND DT 2022 AND VI 27 AND IP 1
Results: 29
Current status of AYA-generation breast cancer: trends worldwide and in Japan.
- Published in:
- International Journal of Clinical Oncology, 2022, v. 27, n. 1, p. 16, doi. 10.1007/s10147-021-02087-4
- By:
- Publication type:
- Article
Correction to: Medical guidelines for Li–Fraumeni syndrome 2019, version 1.1.
- Published in:
- 2022
- By:
- Publication type:
- Correction Notice
Retraction Note to: Inhibition of TMEM16A suppresses growth and induces apoptosis in hepatocellular carcinoma.
- Published in:
- 2022
- By:
- Publication type:
- Correction Notice
Changes of cancer diagnosis disclosure to children in Japan in the last 20 years.
- Published in:
- International Journal of Clinical Oncology, 2022, v. 27, n. 1, p. 245, doi. 10.1007/s10147-021-02038-z
- By:
- Publication type:
- Article
Comparison of treatment outcomes of pelvis external radiotherapy with and without vaginal brachytherapy for cervical cancer patients with positive or close vaginal resected margins.
- Published in:
- International Journal of Clinical Oncology, 2022, v. 27, n. 1, p. 202, doi. 10.1007/s10147-021-02037-0
- By:
- Publication type:
- Article
Large and diffuse ductal carcinoma in situ: potentially lethal subtypes of "preinvasive" disease.
- Published in:
- International Journal of Clinical Oncology, 2022, v. 27, n. 1, p. 121, doi. 10.1007/s10147-021-02036-1
- By:
- Publication type:
- Article
Heterogeneous distribution of PD-L1 expression in the IASLC/ATS/ERS classification of lung adenocarcinoma.
- Published in:
- International Journal of Clinical Oncology, 2022, v. 27, n. 1, p. 105, doi. 10.1007/s10147-021-02035-2
- By:
- Publication type:
- Article
Phase 2 study of axicabtagene ciloleucel in Japanese patients with relapsed or refractory large B-cell lymphoma.
- Published in:
- International Journal of Clinical Oncology, 2022, v. 27, n. 1, p. 213, doi. 10.1007/s10147-021-02033-4
- By:
- Publication type:
- Article
Clinical practice guideline for the treatment of malignant ascites: section summary in Clinical Practice Guideline for peritoneal dissemination (2021).
- Published in:
- International Journal of Clinical Oncology, 2022, v. 27, n. 1, p. 1, doi. 10.1007/s10147-021-02077-6
- By:
- Publication type:
- Article
Key promoters of tumor hallmarks.
- Published in:
- International Journal of Clinical Oncology, 2022, v. 27, n. 1, p. 45, doi. 10.1007/s10147-021-02074-9
- By:
- Publication type:
- Article
Cancer in adolescents and young adults in Japan: epidemiology and cancer strategy.
- Published in:
- International Journal of Clinical Oncology, 2022, v. 27, n. 1, p. 7, doi. 10.1007/s10147-021-02064-x
- By:
- Publication type:
- Article
Current state of fertility preservation for adolescent and young adult patients with gynecological cancer.
- Published in:
- International Journal of Clinical Oncology, 2022, v. 27, n. 1, p. 25, doi. 10.1007/s10147-021-02063-y
- By:
- Publication type:
- Article
Preoperative sarcopenia is a poor prognostic factor in lower rectal cancer patients undergoing neoadjuvant chemoradiotherapy: a retrospective study.
- Published in:
- International Journal of Clinical Oncology, 2022, v. 27, n. 1, p. 141, doi. 10.1007/s10147-021-02062-z
- By:
- Publication type:
- Article
Pretreatment clinical and hematologic prognostic factors of metastatic urothelial carcinoma treated with pembrolizumab: a systematic review and meta-analysis.
- Published in:
- International Journal of Clinical Oncology, 2022, v. 27, n. 1, p. 59, doi. 10.1007/s10147-021-02061-0
- By:
- Publication type:
- Article
Correction to: An analysis of tumor-related skin temperature differences in malignant soft-tissue tumors.
- Published in:
- 2022
- By:
- Publication type:
- Correction Notice
Critical appraisal of epigenetic regulation of galectins in cancer.
- Published in:
- International Journal of Clinical Oncology, 2022, v. 27, n. 1, p. 35, doi. 10.1007/s10147-021-02048-x
- By:
- Publication type:
- Article
Outcomes of long-term nivolumab and subsequent chemotherapy in Japanese patients with head and neck cancer: 2-year follow-up from a multicenter real-world study.
- Published in:
- International Journal of Clinical Oncology, 2022, v. 27, n. 1, p. 95, doi. 10.1007/s10147-021-02047-y
- By:
- Publication type:
- Article
Chronological transition in outcome of second-line treatment in patients with metastatic urothelial cancer after pembrolizumab approval: a multicenter retrospective analysis.
- Published in:
- International Journal of Clinical Oncology, 2022, v. 27, n. 1, p. 165, doi. 10.1007/s10147-021-02046-z
- By:
- Publication type:
- Article
Presence of serum RalA and serum p53 autoantibodies in 1833 patients with various types of cancers.
- Published in:
- International Journal of Clinical Oncology, 2022, v. 27, n. 1, p. 72, doi. 10.1007/s10147-021-02045-0
- By:
- Publication type:
- Article
An analysis of tumor-related skin temperature differences in malignant soft-tissue tumors.
- Published in:
- International Journal of Clinical Oncology, 2022, v. 27, n. 1, p. 234, doi. 10.1007/s10147-021-02044-1
- By:
- Publication type:
- Article
Osimertinib in poor performance status patients with T790M-positive advanced non-small-cell lung cancer after progression of first- and second-generation EGFR-TKI treatments (NEJ032B).
- Published in:
- International Journal of Clinical Oncology, 2022, v. 27, n. 1, p. 112, doi. 10.1007/s10147-021-02043-2
- By:
- Publication type:
- Article
The Real-World status and risk factors for a poor prognosis in elderly patients with primary central nervous system malignant lymphomas: a multicenter, retrospective cohort study of the Tohoku Brain Tumor Study Group.
- Published in:
- International Journal of Clinical Oncology, 2022, v. 27, n. 1, p. 77, doi. 10.1007/s10147-021-02042-3
- By:
- Publication type:
- Article
Deferred radical prostatectomy in patients who initially elected for active surveillance: a multi-institutional, prospective, observational cohort of the PRIAS-JAPAN study.
- Published in:
- International Journal of Clinical Oncology, 2022, v. 27, n. 1, p. 194, doi. 10.1007/s10147-021-02041-4
- By:
- Publication type:
- Article
How long is long enough to secure disease control after low-dose-rate brachytherapy in combination with other modalities in intermediate-risk, localized prostate cancer?
- Published in:
- International Journal of Clinical Oncology, 2022, v. 27, n. 1, p. 184, doi. 10.1007/s10147-021-02040-5
- By:
- Publication type:
- Article
Clinical impact of primary tumour <sup>123</sup>ImIBG response to induction chemotherapy in children with high-risk neuroblastoma.
- Published in:
- International Journal of Clinical Oncology, 2022, v. 27, n. 1, p. 253, doi. 10.1007/s10147-021-02039-y
- By:
- Publication type:
- Article
Sarcopenia is associated with survival in patients with urothelial carcinoma treated with systemic chemotherapy.
- Published in:
- International Journal of Clinical Oncology, 2022, v. 27, n. 1, p. 175, doi. 10.1007/s10147-021-02032-5
- By:
- Publication type:
- Article
Preoperative transferrin level is a novel indicator of short- and long-term outcomes after esophageal cancer surgery.
- Published in:
- International Journal of Clinical Oncology, 2022, v. 27, n. 1, p. 131, doi. 10.1007/s10147-021-02031-6
- By:
- Publication type:
- Article
A phase 2, open-label, multicenter study of ixazomib plus lenalidomide and dexamethasone in adult Japanese patients with relapsed and/or refractory multiple myeloma.
- Published in:
- International Journal of Clinical Oncology, 2022, v. 27, n. 1, p. 224, doi. 10.1007/s10147-021-02030-7
- By:
- Publication type:
- Article
Pembrolizumab plus axitinib versus sunitinib in metastatic renal cell carcinoma: outcomes of Japanese patients enrolled in the randomized, phase III, open-label KEYNOTE-426 study.
- Published in:
- International Journal of Clinical Oncology, 2022, v. 27, n. 1, p. 154, doi. 10.1007/s10147-021-02014-7
- By:
- Publication type:
- Article